Slovenia's Lek Registers Drugs for Parkinsons Disease in the U.S.
Ljubljana, 31 January - The U.S. Food and Drug Administration on 28 January gave the green light to the Slovene company Lek to sell on the U.S. market bromokriptin in the form of tablets, a medicine curing Parkinsons disease, Lek said on Thursday.
The rest of this news item is available to subscribers.
The news item consists of 564 characters (without spaces) or 109 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.